{"schema_version":"secwatch.filing_event.v1","accession":"0001722482-21-000257","form_type":"8-K","ticker":"AVTR","cik":"0001722482","company_name":"Avantor, Inc.","filed_at":"2021-11-02T23:59:59+00:00","discovered_at":"2026-05-14T18:04:13.834337+00:00","generated_at":"2026-06-28T15:16:44.595011+00:00","sec_items":["1.01","2.03","5.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Avantor completes $900M term loan amendment to fund Curie acquisition; appoints Mala Murthy to board","bullets":["Obtained $900M in incremental B-5 term loans at LIBOR+2.25% (0.50% floor), maturing Nov 2027.","Proceeds used to fund acquisition of Curie Holdings, LLC and refinance existing Curie debt.","Mala Murthy, CFO of Teladoc Health, appointed as Class I independent director effective Dec 1, 2021.","Murthy to serve on Audit and Finance Committee; receives standard non-employee director compensation."],"urls":{"canonical":"https://secwatch.observer/filing/0001722482-21-000257","json":"https://secwatch.observer/filing/0001722482-21-000257.json","markdown":"https://secwatch.observer/filing/0001722482-21-000257.md","text":"https://secwatch.observer/filing/0001722482-21-000257.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1722482/000172248221000257/0001722482-21-000257-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1722482/000172248221000257/avtr-20211028.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T15:16:44.595011+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ce9436a3b0","claim":"Mala Murthy was appointed as Class I director at Avantor, Inc..","evidence_excerpt":"On October 28, 2021, the Board, upon the recommendation of its Nominating and Governance Committee, appointed Mala Murthy as a Class I director with an initial term expiring at the Company’s 2022 Annual Meeting of Stockholders.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1722482/000172248221000257/0001722482-21-000257-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class I director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}